Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation
Salat, C.; Holler, E.; Hiller, E.; Pihusch, R.; Kolb, H.J.
Haematologica 84 Suppl Eha-4: 40-43
1999
ISSN/ISBN: 0390-6078 PMID: 10907464 Document Number: 506459
Document emailed within 1 workday
Related Documents
Grandt, N.C. 1989: Hepatic veno-occlusive disease following bone marrow transplantation Oncology Nursing Forum 16(6): 813-817Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Gluckman, E.; Jolivet, I.; Scrobohaci, M.L.; Devergie, A.; Traineau, R.; Bourdeau-Espérou, H.; Lehn, P.; Faure, P.; Drouet, L. 1990: Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation Nouvelle Revue Francaise d'Hematologie 32(1): 1-3
Duncan, N.; Hewetson, M.; Powles, R.; Raje, N.; Mehta, J. 1996: An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplantation 18(6): 1175-1178
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Or, R.; Nagler, A.; Shpilberg, O.; Elad, S.; Naparstek, E.; Kapelushnik, J.; Cass, Y.; Gillis, S.; Chetrit, A.; Slavin, S.; Eldor, A. 1996: Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients Transplantation 61(7): 1067-1071
Benesová, P.; Dĕdic, K.; Zák, P.; Voglová, J. 2004: Complete regression of bone marrow fibrosis following allogeneic peripheral blood stem cell transplantation in a patient with idiopathic myelofibrosis Ceskoslovenska Patologie 40(4): 167-171
Endo, M.; Tanosaki, R. 1995: Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(12): 1762-1770
Ghavamzadeh, A.; Iravani, M.; Jabehdar-Maralani, P.; Hajrasouliha, A.; Tavakoli, S. 2003: Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran Haematologica 88(4): Elt13
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Rio, B.; Zittoun, R.; Ifrah, N.; Aubert, J.; Pene, F. 1984: Incidence and severity of veno-occlusive diseases of the liver after bone marrow transplantation Presse Medicale 13(43): 2648
Powles, R.; Mehta, J.; Singhal, S.; Horton, C.; Tait, D.; Milan, S.; Pollard, C.; Lumley, H.; Matthey, F.; Shirley, J. 1995: Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center Bone Marrow Transplantation 16(2): 241-247
Cottler-Fox, M.; Read, E.J.; Yu, M.; Carter, C.; Klein, H.G. 1992: Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation Progress in Clinical and Biological Research 377: 569-573
Gratwohl, A. 1996: Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases Therapeutische Umschau. Revue Therapeutique 53(2): 152-157
Tarella, C.; Gavarotti, P.; Caracciolo, D.; Locatelli, F.; Falda, M.; Paolino, F.; Lovisone, E.; Sormano, E.; Tassi, V.; Urgesi, A. 1990: Use of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantation Haematologica 75 Suppl. 1: 90-94
Lanfranchi, A.; Verardi, R.; Tettoni, K.; Neva, A.; Mazzolari, E.; Pennacchio, M.; Pasic, S.; Ugazio, A.G.; Albertini, A.; Porta, F. 2000: Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency Haematologica 85(11 Suppl): 41-46
Rosenfeld, C.S.; Gremba, C.; Shadduck, R.K.; Zeigler, Z.R.; Nemunaitis, J. 1994: Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation Experimental Hematology 22(3): 290-294
Jungerman, M.; Sedzimirska, M.; Lange, A.; Witt, M. 1998: Application of microsatellite markers for monitoring of reconstitution pattern in patients after bone marrow transplantation/peripheral blood progenitor cell transplantation Archivum Immunologiae et Therapiae Experimentalis 46(1): 39-43
Janssen, W.E.; Lee, C.; Farmelo, M.J.; Smilee, R.; Barth, K.; Fields, K.K.; Zorsky, P.E.; Elfenbein, G.J. 1992: Use of CD34+ cell fraction as a measure of hematopoietic stem cells in bone marrow and peripheral blood: comparison with the CFU-GM assay Progress in Clinical and Biological Research 377: 513-521